| Record ID | harvard_bibliographic_metadata/ab.bib.10.20150123.full.mrc:437729050:1311 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.10.20150123.full.mrc:437729050:1311?format=raw |
LEADER: 01311cam a2200361 a 4500
001 010571450-X
005 20070614115945.0
008 050929s2006 enka b 001 0 eng
015 $aGBA599236$2bnb
016 7 $a013343266$2Uk
020 $a1841845795 (hbk.)
020 $a9781841845791 (hbk.)
035 0 $aocm62344716
040 $aUKM$cUKM$dBAKER$dBWKUK$dVET$dYDXCP$dOCLCQ$dBTCTA
050 4 $aRC684.A52$bA543 2006
082 04 $a615.71$222
245 00 $aAngiotensin II receptor antagonists :$bcurrent perspectives /$cedited by Giuseppe Mancia.
246 3 $aAngiotensin 2 antagonists in perspective
246 3 $aAngiotensin two antagonists in perspective
250 $a2nd ed.
260 $aAbingdon [England] :$bInforma Healthcare ;$aBoca Raton, Fla. :$bDistributed in North America by Taylor & Francis,$c2006.
300 $axii, 218 p. :$bill. (some col.) ;$c24 cm.
500 $aPrevious ed.: 2000.
504 $aIncludes bibliographical references and index.
650 0 $aSaralasin.
650 0 $aAngiotensins.
650 0 $aVasoconstrictors.
650 12 $aReceptors, Angiotensin$xantagonists & inhibitors.
650 22 $aAntihypertensive Agents$xpharmacology.
650 22 $aAntihypertensive Agents$xtherapeutic use.
700 1 $aMancia, Giuseppe.
988 $a20070614
906 $0OCLC